Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
NDA SPONSORS SHOULD RESPOND TO REVIEWER REQUESTS FOR CASE REPORTS, TABULATIONS IN 30 DAYS; FDA ISSUES GUIDELINES, STAFF MANUAL GUIDE ON NDA REWRITE REGULATIONS
Jul 01 1985
•
By
The Pink Sheet
More from Archive
More from Pink Sheet